Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials

Journal of Clinical Epidemiology

Volumn 41, Issue 11, 1988, Pages 1037-1041

  Pincus, Theodore ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE;

CHRONIC DISEASE; CLINICAL TRIAL; EDITORIAL; HUMAN; LABORATORY DIAGNOSIS; METHODOLOGY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY; REMISSION; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; HUMAN; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DROPOUTS; PROGNOSIS; TIME FACTORS;

EID: 0024208901     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(88)90072-8     Document Type: Editorial

References (53)

1. Disease-modifying drugs for progressive rheumatoid arthritis
2. Rheumatoid arthritisdisease modifying drugs
3. Work disability in rheumatoid arthritis: Effects of disease, social and work factors
4. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
5. The development of disability in rheumatoid arthritis
6. Long-term outcome of treating rheumatoid arthritis: results after 20 years
7. Rheumatoid arthritis and mortality
8. Taking mortality in rheumatoid arthritis seriously … predictive markers, socioeconomic status and comorbidity. Editorial
9. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid athritis
10. Editorial: Questions on clinical trials
11. Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias
12. Reporting on methods in clinical trials
13. An additional basic science for clinical medicine: Il. The limitations of randomized trials
14. Revision of diagnostic criteria for rheumatoid arthritis
15. Revised criteria for the classification of rheumatoid arthritis
16. The prevalence of RA: follow-up evaluation of the effect of criteria on rates in Sudbury Massachusetts
17. Articular patterns in the early course of rheumatoid arthritis
18. The clinical features of rheumatoid arthritis
19. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?
20. Gold therapy in rheumatoid arthritis-Report of a multi-centre controlled trial
21. Rheumatoid arthritis
22. Length of life and cause of death in rheumatoid arthritis
23. The prognosis of rheumatoid arthritis
24. The death certificate in rheumatoid arthritis
25. Increased mortality among persons with rheumatoid arthritis but where RA does not appear on death certificate
26. Preference for endpoint measures in clinical trials: results of structured workshops
27. Predictors of medical intervention in adult rheumatoid arthritis
28. Quantitative nonlaboratory measures to monitor and predict the course of rheumatoid arthritis
29. Measurement of patient outcome in arthritis
30. Measuring health status in arthritis: the Arthritis Impact Measurement Scales
31. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
32. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research
33. Scientific and clinical problems in indexes of functional disability
34. The status of patient status measures (editorial)
35. Outcome assessment in clinical trials: evidence for the sensitivity of a health status measure
36. Toward clinical applications of health status measures: sensitivity of scales to clinically important changes
37. Auranofin therapy and quality of life in patients with rheumatoid arthritis
38. A controlled trial of gold salt therapy in rheumatoid arthritis
39. Gold salts in the treatment of rheumatoid arthritis. A double-blind study
40. Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis
41. Chrysotherapy. A prospective study
42. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis
43. Relation of education to sudden death after myocardial infarction
44. Employment grade and coronary heart disease in British civil servants
45. Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 184 United States population
46. Practical results of treatment with disease-modifying antirheumatoid drugs
47. Remission in rheumatoid arthritis